On Wednesday, several major firms issued notable analyst actions. UBS upgraded Invesco from Neutral to Buy, citing an undervalued stock with a $41 price target and highlighting the durability of its growth profile. Raymond James initiated coverage of M&T Bank as Outperform, calling it a high‑performing bank with a $250 target. Morgan Stanley moved Nexa Resources to Overweight from Equal Weight, noting compelling valuation and strong free‑cash‑flow yields. KeyBanc raised Corteva to Overweight, describing the stock as deep value territory with a $17 target after the VYLR spin‑off. Jefferies started coverage of Ambiq Micro at Buy, citing high potential and a $90 target. Citi upgraded Flutter to Buy from Neutral, buying the weakness with a $91 target and pointing to strong Q3 US adjusted EBITDA prospects. Oppenheimer initiated Brown & Brown as Outperform, seeing about 20% upside to a $73 target. JPMorgan moved Afya to Overweight from Neutral, finding the Latin American medical education firm attractive. HSBC upgraded Allstate from Hold to Buy, citing ample upside. KBW raised Moelis & Co to Outperform from Market Perform, expecting improved deal activity in the sub‑$10B segment, while downgrading PJT to Market Perform. Morgan Stanley reiterated its Overweight stance on SpaceX, emphasizing the firm’s role in turning energy into intelligence via onboard robots and forecasting millions of jobs. TD Cowen upgraded Marvell to Buy from Hold, saying growth drivers have shifted to its connectivity franchise and that custom XPU risks are largely derisked. Citi lifted XPO to Buy from Neutral after its decline from $230 to $183, citing upside potential for share gains and pricing strength. UBS kept Tesla at Neutral but lifted the price target to $391 from $385, noting long‑term physical ventures could provide a floor. Barclays initiated Abbott Labs as Overweight, highlighting its $50 billion revenue and diversified healthcare pipeline. Seaport began coverage of Solstice Advanced Materials with a Buy rating and $80 target, calling it a leader in high‑performance specialty materials. Yorkville Ives initiated Nvidia and Apple as Outperform, setting targets of $300 and $400 respectively and praising Nvidia’s competitive advantage and Apple’s new ecosystem phase. Morgan Stanley upgraded Gold Fields to Overweight from Equal Weight, recommending a dip‑buy. Evercore ISI lifted NetApp to Outperform from In Line, raising the target to $300 on conservative‑looking growth. JPMorgan initiated Savara as Overweight with a December 2027 price target of $12, seeing substantial upside. Oppenheimer launched coverage of SailPoint Technologies as Outperform, citing its leadership in identity governance across humans, machines and AI agents with a $30 target. Cantor Fitzgerald upgraded Humana to Overweight from Neutral, raising the target to $460 and boosting earnings forecasts. DA Davidson reiterated its Buy on Micron, increasing the target to $3,000 from $2,100 after investor meetings. Northcoast lifted nLight to Buy from Neutral, viewing the recent pullback from supply‑chain issues as a buying opportunity with a $75 target. Deutsche Bank initiated AptarGroup as Buy, seeing margin expansion opportunities and setting a $150 target.
Also Read
- Pakistani Diplomat Highlights Humane, Digitized Fuel Subsidy Initiative Led by PM Sharif
- British Jewish groups to hold London vigil for victims of 7 October attacks
- Washington Endorses Enhanced AU-UN Cooperation, Backs UN Funding Mechanism for African Peace Operations
- Iran Parliament Passes Measure Penalizing Contact With Designated ‘Hostile’ Foreign Outlets


